A January 2025 Cell Metabolism study reveals obesity induces lasting epigenetic changes in T cells, causing persistent inflammation even after weight loss, challenging current recovery assumptions. Ne...
A new study reveals that dasatinib and quercetin (D+Q) cause demyelination in mice, raising safety concerns as over 30 clinical trials test the combo for age-related diseases. A study in Nature Aging ...
UK Biobank data links long-term PM2.5 and NO2 exposure to epigenetic aging and brain volume loss, increasing dementia risk by up to 40%. Long-term exposure to air pollutants accelerates biological agi...
Recent studies show senescent cells can both help and hinder wound repair. Understanding this balance offers new therapeutic strategies for chronic wounds and aging. Senescent cells are not just ̵...
Recent research uncovers strong correlations between gut bacteria composition and physical function in seniors, suggesting microbiome-targeted interventions could combat frailty. Can the bacteria in y...
Senolytics like dasatinib and quercetin are transforming dermatology from cosmetic fixes to true biological rejuvenation, with recent trials showing improved skin elasticity and potential for treating...
A comparative study reveals that dasatinib-quercetin reduces senescence and fibrosis in intervertebral disc degeneration, while navitoclax shows no benefit, highlighting DQ’s potential for affor...
New research links exercise-induced gut microbiome changes to better physical function in seniors, suggesting personalized probiotics could enhance healthy aging. Regular moderate activity boosts bene...
Dermatology is shifting from surface-level cosmetics to biology-driven interventions targeting aging hallmarks, with senolytics, epigenetic reprogramming, and biomimetic peptides leading the charge. D...
Large animals like whales and elephants have evolved superior DNA repair and cancer suppression mechanisms, offering insights for human aging and disease prevention. New studies reveal how massive mam...
